<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2020-99-2-140-144</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-199</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОБЛЕМНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROBLEM-SOLVING ARTICLES</subject></subj-group></article-categories><title-group><article-title>Диагностические критерии прогрессирования хронической обструктивной болезни лёгких в условиях повышенной техногенной нагрузки</article-title><trans-title-group xml:lang="en"><trans-title>Diagnostic criteria for the progression of the chronic obstructive pulmonary disease under a high technogenic load</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1009-9011</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Виткина</surname><given-names>Т. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vitkina</surname><given-names>T. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4201-9167</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сидлецкая</surname><given-names>Каролина Андреевна</given-names></name><name name-style="western" xml:lang="en"><surname>Sidletskaya</surname><given-names>Karolina A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аспирант лаборатории медицинской экологии и рекреационных ресурсов Владивостокского филиала ДНЦ ФПД – НИИМКВЛ, 690105, Владивосток.</p><p>e-mail: d-karolina-a@mail.ru</p></bio><bio xml:lang="en"><p>MD, postgraduate student of the Laboratory of Medical Ecology and Recreational Resources of the Vladivostok Branch of the Far Eastern Scientific Center of Physiology and Pathology of Respiration, Institute of Medical Climatology and Rehabilitative Treatment, Vladivostok, 690105, Russian Federation.</p><p>e-mail: d-karolina-a@mail.ru</p></bio><email xlink:type="simple">d-karolina-a@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Владивостокский филиал Федерального государственного бюджетного научного учреждения «Дальневосточный научный центр физиологии и патологии дыхания» - Научно-исследовательский институт медицинской климатологии и восстановительного лечения</institution></aff><aff xml:lang="en"><institution>Vladivostok Branch of the Far Eastern Scientific Center of Physiology and Pathology of Respiration, Institute of Medical Climatology and Rehabilitative Treatment</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>03</month><year>2020</year></pub-date><volume>99</volume><issue>2</issue><fpage>140</fpage><lpage>144</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Виткина Т.И., Сидлецкая К.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Виткина Т.И., Сидлецкая К.А.</copyright-holder><copyright-holder xml:lang="en">Vitkina T.I., Sidletskaya K.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/199">https://www.rjhas.ru/jour/article/view/199</self-uri><abstract><sec><title>Введение</title><p>Введение. Широкая распространённость и рост заболеваемости хронической обструктивной болезнью лёгких (ХОБЛ) обусловливает необходимость поиска новых подходов к диагностике прогрессирования этого заболевания. Загрязнение воздуха вызывает дополнительную нагрузку на больных ХОБЛ, способствуя утяжелению течения патологии. Исследование механизмов его воздействия на развитие воспалительного ответа при ХОБЛ является весьма актуальной задачей. </p><p>Цель - установить динамику экспрессии интерлейкина-4 (IL-4), IL-6 и их мембранных рецепторов (IL-4R, IL-6R) на Т-хелперах крови при прогрессировании ХОБЛ у пациентов, живущих на территории с высоким техногенным прессингом. </p></sec><sec><title>Материал и методы</title><p>Материал и методы. Владивосток был выбран в качестве региона со значительным техногенным загрязнением воздушной среды - количество веществ, загрязняющих воздушную среду, составляет 59,9 тыс. тонн в год, 80% из которых составляют автомобильные выбросы; приземный слой воздуха характеризуется преобладанием частиц менее 10 мкм, оказывающих наиболее патогенное воздействие на респираторную систему. Были обследованы больные ХОБЛ лёгкой (36 человек), средней (52 человека), тяжёлой (24 человека) степени тяжести стабильного течения, проживающих в г. Владивостоке не менее 5 лет. Контрольную группу составили здоровые добровольцы, проживающие на той же территории (32 человека). Уровни IL-4, IL-6 в плазме крови и количество Т-хелперов, экспрессирующих IL-4R и IL-6R, определяли методом проточной цитометрии.</p></sec><sec><title>Результаты</title><p> Результаты. В ходе исследования было выявлено, что у больных ХОБЛ, подверженных постоянному влиянию загрязнения воздуха, происходит снижение концентрации IL-4 и повышение уровня IL-6. Установлено снижение экспрессии IL-4R на Т-хелперах крови на всех стадиях ХОБЛ и повышение экспрессии IL-6R на Т-хелперах крови по мере прогрессирования заболевания. </p></sec><sec><title>Заключение</title><p>Заключение. Данные об экспрессии IL-6R и IL-4R на циркулирующих Т-хелперах могут быть использованы для диагностики прогрессирования ХОБЛ у пациентов, живущих в условиях урбанизированной территории.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The prevalence and gain in the incidence of chronic obstructive pulmonary disease (COPD) is a reason to search for new approaches to the diagnosis of its progression. Air pollution causes an additional burden on COPD patients, contributing to the progression of this pathology. The study of mechanisms of its impact on the inflammatory response in COPD is an urgent task. </p><p>The aim is to establish the dynamics of expression of interleukin-4 (IL-4), IL-6 and their membrane receptors (IL-4R, IL-6R) in blood T-helpers during COPD progression in patients living in areas with the high technogenic load. </p></sec><sec><title>Material and methods</title><p>Material and methods. Vladivostok was chosen as a region with significant technogenic air pollution - the amount of air pollutants is 59.9 thousand tons per year, with 80% related to vehicle emissions; the surface layer of air is characterized by a predominance of particles less than 10 µm, which are the most pathogenic for the respiratory system. Patients with stable mild (36), moderate (52 ) and severe COPD (24) patients living in Vladivostok for at least 5 years were examined. The control group consisted of healthy volunteers living in the same area (32cases). The levels of IL-4, IL-6 in plasma and the number of T-helper cells expressing IL-4R and IL-6R were determined by flow cytometry.</p></sec><sec><title>Results</title><p> Results. A decline in serum IL-4 concentration and an increase in serum IL-6 level in COPD patients living under constant air pollution has been found. A decrease in IL-4R expression in blood T-helpers at all COPD stages and the gain in IL-6R synthesis in blood T-helpers during the progression of COPD were established.</p></sec><sec><title>Conclusion</title><p> Conclusion. Data on the expression of IL-6R and IL-4R on circulating T-helpers can be used to diagnose the progression of COPD in patients living in urbanized areas.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая обструктивная болезнь лёгких</kwd><kwd>урбанизированная территория</kwd><kwd>мембранный рецептор к интерлейкину-4</kwd><kwd>мембранный рецептор к интерлейкину-6</kwd><kwd>Т-хелперы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic obstructive pulmonary disease</kwd><kwd>urbanized territory</kwd><kwd>membrane receptor to interleukine-4</kwd><kwd>membrane receptor to interleukine-6</kwd><kwd>T-helper cells</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obctructive pulmonary disease. 2014. [Electronic resourse]. Available at: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdf.2</mixed-citation><mixed-citation xml:lang="en">Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obctructive pulmonary disease. 2014. [Electronic resourse]. Available at: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdf.2</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Berend N. Contribution of air pollution to COPD and small airway dysfunction. Respirology. 2016; 21 (2): 237-44. https://doi.org/10.1111/resp.12644</mixed-citation><mixed-citation xml:lang="en">Berend N. Contribution of air pollution to COPD and small airway dysfunction. Respirology. 2016; 21 (2): 237–44. https://doi.org/10.1111/resp.12644</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Calderon-Garciduenas L., Mora-Tiscareno A., Francolira M., Torres-Jardon R., Pena-Cruz B., Palacios-Lopez C. et al. Exposure to Urban Air Pollution and Bone Health in Clinically Healthy Six-year-old Children. Arh Hig Rada Toksikol. 2013; 64 (1): 23-34. https://doi.org/10.2478/10004-1254-64-2013-2219</mixed-citation><mixed-citation xml:lang="en">Calderon-Garciduenas L., Mora-Tiscareno A., Francolira M., Torres-Jardon R., Pena-Cruz B., Palacios-Lopez C. et al. Exposure to Urban Air Pollution and Bone Health in Clinically Healthy Six-year-old Children. Arh Hig Rada Toksikol. 2013; 64 (1): 23–34. https://doi.org/10.2478/10004-1254-64-2013-2219</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gruzieva O., Merid S.K., Gref A., Gajulapuri A., Lemonnier N., Ballereau S. et al. Exposure to traffic-related air pollution and serum inflammatory cytokines in children. Environ Health Perspect. 2017; 125 (6): 067007-1-067007-8. https://doi.org/10.1289/EHP460</mixed-citation><mixed-citation xml:lang="en">Gruzieva O., Merid S.K., Gref A., Gajulapuri A., Lemonnier N., Ballereau S. et al. Exposure to traffic-related air pollution and serum inflammatory cytokines in children. Environ Health Perspect. 2017; 125 (6): 067007-1-067007-8. https://doi.org/10.1289/EHP460</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Heinrich J., Schikowski T. COPD Patients as Vulnerable Subpopulation for Exposure to Ambient Air Pollution. Curr Environ Health Rep. 2018; 5 (1): 70-6. https://doi.org/10.1007/s40572-018-0178-z</mixed-citation><mixed-citation xml:lang="en">Heinrich J., Schikowski T. COPD Patients as Vulnerable Subpopulation for Exposure to Ambient Air Pollution. Curr Environ Health Rep. 2018; 5 (1): 70–6. https://doi.org/10.1007/s40572-018-0178-z</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Khafaie M.A., Yajnik C.S., Salvi S.S., Ojha A. Critical review of air pollution health effects with special concern on respiratory health. J Air Pollut Health. 2016; 1 (2): 123-36.</mixed-citation><mixed-citation xml:lang="en">Khafaie M.A., Yajnik C.S., Salvi S.S., Ojha A. Critical review of air pollution health effects with special concern on respiratory health. J Air Pollut Health. 2016; 1 (2): 123–36.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Klumper C., Kramer U., Lehmann I., von Berg A., Berdel D., Herberth G. et al. Air pollution and cytokine responsiveness in asthmatic and non-asthmatic children. Environ Res. 2015; 138: 381-90. https://doi.org/10.1016/j.envres.2015.02.034</mixed-citation><mixed-citation xml:lang="en">Klumper C., Kramer U., Lehmann I., von Berg A., Berdel D., Herberth G. et al. Air pollution and cytokine responsiveness in asthmatic and non-asthmatic children. Environ Res. 2015; 138: 381–90. https://doi.org/10.1016/j.envres.2015.02.034</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai D., Amyai N., Marques-Vidal P., Wang J., Riediker M., Mooser V. et al. Effects of particulate matter on inflammatory markers in the general adult population. Part Fibre Toxicol. 2012; 9: 1-24. https://doi.org/10.1186/1743-8977-9-24</mixed-citation><mixed-citation xml:lang="en">Tsai D., Amyai N., Marques-Vidal P., Wang J., Riediker M., Mooser V. et al. Effects of particulate matter on inflammatory markers in the general adult population. Part Fibre Toxicol. 2012; 9: 1–24. https://doi.org/10.1186/1743-8977-9-24</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes P.J. Cellular and molecular mechanisms of asthma and COPD. Clin Sci. 2017; 131 (13): 1541-58. https://doi.org/10.1042/CS20160487</mixed-citation><mixed-citation xml:lang="en">Barnes P.J. Cellular and molecular mechanisms of asthma and COPD. Clin Sci. 2017; 131 (13): 1541–58. https://doi.org/10.1042/CS20160487</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Caramori G., Casolari P., Barczyk A., Durham A.L., Stefano A. et al. COPD immunopathology. Semin Immunopathol. 2016; 38 (4): 497-515. https://doi.org/10.1007/s00281-016-0561-5</mixed-citation><mixed-citation xml:lang="en">Caramori G., Casolari P., Barczyk A., Durham A.L., Stefano A. et al. COPD immunopathology. Semin Immunopathol. 2016; 38 (4): 497–515. https://doi.org/10.1007/s00281-016-0561-5</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Калинина Е.П., Виткина Т.И., Кнышова В.В., Федосеева Е.А., Новгородцева Т.П., Гвозденко Т.А. Клинико-иммунологическое сопоставление при Th-зависимых механизмах иммунного ответа у больных хронической обструктивной болезнью лёгких. Медицинская иммунология. 2018; 20 (6): 855-64. https://doi.org/10.15789/1563-0625-2018-6-855-864</mixed-citation><mixed-citation xml:lang="en">Kalinina E.P., Vitkina T.I., Knyshova V.V., Fedoseeva E.A., Novgorodtseva T.P., Gvozdenko T.A. Clinical and immunological comparison in patients with chronic obstructive pulmonary disease with Th-dependent mechanisms of the immune response. Meditsinskaya immunologiya [Medical Immunology]. 2018; 20 (6): 855–64. https://doi.org/10.15789/1563-0625-2018-6-855-864 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ardestani M.E., Zaerin O. Role of serum interleukin 6, albumin and C-reactive protein in COPD patients. Tanaffos. 2015; 14 (2): 134-40.</mixed-citation><mixed-citation xml:lang="en">Ardestani M.E., Zaerin O. Role of serum interleukin 6, albumin and C-reactive protein in COPD patients. Tanaffos. 2015; 14 (2): 134–40.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bradford E., Jacobson S., Varasteh J., Comellas A.P., Woodruff P., O’Neal W. et al. The value of blood cytokines and chemokines in assessing COPD. Respir Res. 2017; 18 (1). https://doi.org/10.1186/s12931-017-0662-2</mixed-citation><mixed-citation xml:lang="en">Bradford E., Jacobson S., Varasteh J., Comellas A.P., Woodruff P., O’Neal W. et al. The value of blood cytokines and chemokines in assessing COPD. Respir Res. 2017; 18 (1). https://doi.org/10.1186/s12931-017-0662-2</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Emami A.M., Zaerin O. Role of Serum Interleukin 6, albumin and C-reactive protein in COPD patients. Tanaffos. 2015; 14 (2): 134-40.</mixed-citation><mixed-citation xml:lang="en">Emami A.M., Zaerin O. Role of Serum Interleukin 6, albumin and C-reactive protein in COPD patients. Tanaffos. 2015; 14 (2): 134–40.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Singh S., Verma S.K., Kumar S., Ahmad M.K., Nischal A., S.K. Singh et al. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers. Immunol Lett. 2018; 196: 1-10. https://doi.org/10.1016/j.imlet.2018.01.004</mixed-citation><mixed-citation xml:lang="en">Singh S., Verma S.K., Kumar S., Ahmad M.K., Nischal A., S.K. Singh et al. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers. Immunol Lett. 2018; 196: 1–10. https://doi.org/10.1016/j.imlet.2018.01.004</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Selvarajah S., Todd I., Tighe P.J., John M., Bolton C.E., Harrison T. et al. Multiple circulating cytokines are coelevated in chronic obstructive pulmonary disease. Mediators Inflamm. 2016; 2016: 3604842. https://doi.org/10.1155/2016/3604842</mixed-citation><mixed-citation xml:lang="en">Selvarajah S., Todd I., Tighe P.J., John M., Bolton C.E., Harrison T. et al. Multiple circulating cytokines are coelevated in chronic obstructive pulmonary disease. Mediators Inflamm. 2016; 2016: 3604842. https://doi.org/doi.org/10.1155/2016/3604842</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Vitkina T.I., Denisenko Yu.K., Davydova K.A. The changes in the profile of cytokines in progressing chronic obstructive pulmonary disease. Int Res J. 2016; 49 (7-3): 6-8. https://doi.org/10.18454/IRJ.2016.49.024</mixed-citation><mixed-citation xml:lang="en">Vitkina T.I., Denisenko Yu.K., Davydova K.A. The changes in the profile of cytokines in progressing chronic obstructive pulmonary disease. Int Res J. 2016; 49 (7–3): 6–8. https://doi.org/10.18454/IRJ.2016.49.024</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fielding C.A., Jones G.W., McLoughlin R.M., McLeod L., Hammond V.J., Uceda J. et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014; 40 (1): 40-50. https://doi.org/10.1016/j.immuni.2013.10.022</mixed-citation><mixed-citation xml:lang="en">Fielding C.A., Jones G.W., McLoughlin R.M., McLeod L., Hammond V.J., Uceda J. et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014; 40 (1): 40–50. https://doi.org/10.1016/j.immuni.2013.10.022</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Robinson M.B., Deshpande D.A., Chou J., Cui W., Smith S., Langefeld C. et al. IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle. Am J Physiol - Lung Cell Mol Physiol. 2015; 309 (2): L129-L138. https://doi.org/10.1152/ajplung.00288.2014</mixed-citation><mixed-citation xml:lang="en">Robinson M.B., Deshpande D.A., Chou J., Cui W., Smith S., Langefeld C. et al. IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle. Am J Physiol – Lung Cell Mol Physiol. 2015; 309 (2): L129–L138. https://doi.org/10.1152/ajplung.00288.2014</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ruwanpura S.M., McLeod L., Miller A., Jones J., Bozinovski S., Vlahos R. et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Res Cell Mol Biol. 2011; 45 (4): 720-30. https://doi.org/10.1165/rcmb.2010-0462OC</mixed-citation><mixed-citation xml:lang="en">Ruwanpura S.M., McLeod L., Miller A., Jones J., Bozinovski S., Vlahos R. et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Res Cell Mol Biol. 2011; 45 (4): 720–30. https://doi.org/10.1165/rcmb.2010-0462OC</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Конопля Е.Н., Мансимова О.В., Шелухина А.Н., Дорофеева С.Г. Фармакологическая коррекция иммунных нарушений у пациентов с ХОБЛ. Научный медицинский вестник. 2015; (2): 18-24. https://doi.org/10.17117/nm.2015.02.018</mixed-citation><mixed-citation xml:lang="en">Konoplya E.N., Mansimova O.V., Shelukhina A.N., Dorofeeva S.G. Pharmacological correction of immune disorders in patients with COPD. Nauchnyy meditsinskiy vestnik. 2015; (2): 18–24. https://doi.org/10.17117/nm.2015.02.018 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Павленко В.И. Роль цитокинов в формировании иммунологической недостаточности у больных хронической обструктивной болезнью лёгких. International Journal of Immunorehabilitation. 2010; 12 (2): 116.</mixed-citation><mixed-citation xml:lang="en">Pavlenko V.I. The role of cytokines in the formation of immunological failure in patients with chronic obstructive pulmonary disease. International Journal of Immunorehabilitation. 2010; 12 (2): 116. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wolf J., Rose-John S., Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine. 2014; 70 (1): 11-20. https://doi.org/10.1016/j.cyto.2014.05.024</mixed-citation><mixed-citation xml:lang="en">Wolf J., Rose-John S., Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine. 2014; 70 (1): 11–20. https://doi.org/10.1016/j.cyto.2014.05.024</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Веремчук Л.В., Минеева Е.Е., Виткина Т.И., Гвозденко Т.А., Ракитский В.Н., Голохваст К.С. Методология интегральной оценки влияния факторов окружающей среды на функциональное состояние органов дыхания здоровых лиц и больных с бронхолёгочной патологией. Гигиена и санитария. 2018; 97 (3): 269-73. https://doi.org/10.18821/0016-9900-2018-97-3-269-273</mixed-citation><mixed-citation xml:lang="en">Veremchuk L.V., Mineeva E.E., Vitkina T.I., Gvozdenko T.A., Rakitskiy V.N., Golokhvast K.S. The methodology of the integral assessment of the influence of environmental factors on the functional state of the respiratory organs in healthy individuals and patients with bronchopulmonary pathology. Gigiena i sanitariya [Hygiene and Sanitation, Russian journal]. 2018; 97 (3): 269–73. https://doi.org/10.18821/0016-9900-2018-97-3-269-273 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Golokhvast K., Vitkina T., Gvozdenko T., Kolosov V., Yankova V., Kondratieva E. et al. Impact of atmospheric microparticles on the development of oxidative stress in healthy city/industrial seaport residents. Oxid Med Cell Longev. 2015; 2015: 412173. https://doi.org/10.1155/2015/412173</mixed-citation><mixed-citation xml:lang="en">Golokhvast K., Vitkina T., Gvozdenko T., Kolosov V., Yankova V., Kondratieva E. et al. Impact of atmospheric microparticles on the development of oxidative stress in healthy city/industrial seaport residents. Oxid Med Cell Longev. 2015; 2015: 412173. https://doi.org/10.1155/2015/412173</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Barskova L.S., Vitkina T.I., Gvozdenko T.A., Veremchuk L.V., Golokhvast K.S. Assessment of air pollution by small-sized suspended particulate matter in urbanized territories with various technogenic load (on the example of Vladivostok, Russia). Russ Open Med J. 2019; 8 (3). https://doi.org/10.15275/rusomj.2019.0304</mixed-citation><mixed-citation xml:lang="en">Barskova L.S., Vitkina T.I., Gvozdenko T.A., Veremchuk L.V., Golokhvast K.S. Assessment of air pollution by small-sized suspended particulate matter in urbanized territories with various technogenic load (on the example of Vladivostok, Russia). Russ Open Med J. 2019; 8 (3). https://doi.org/10.15275/rusomj.2019.0304</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Veremchuk L.V., Mineeva E.E., Vitkina T.I., Sidletskaya K.A. The impact the atmospheric air dust fractions and toxic metals on external respiratory function among chronic obstructive pulmonary disease patients. IOP Conf Ser Earth Environ Sci. 2019; 227 (5). https://doi.org/10.1088/1755-1315/227/5/052012</mixed-citation><mixed-citation xml:lang="en">Veremchuk L.V., Mineeva E.E., Vitkina T.I., Sidletskaya K.A. The impact the atmospheric air dust fractions and toxic metals on external respiratory function among chronic obstructive pulmonary disease patients. IOP Conf Ser Earth Environ Sci. 2019; 227 (5). https://doi.org/10.1088/1755-1315/227/5/052012</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Veremchuk L.V., Tsarouhas K., Vitkina T.I., Mineeva E.E., Gvozdenko T.A., Antonyuk M.V. et al. Impact evaluation of environmental factors on respiratory function of asthma patients living in urban territory. Environ Pollut. 2018; 235: 489-96. https://doi.org/10.1016/j.envpol.2017.12.122</mixed-citation><mixed-citation xml:lang="en">Veremchuk L.V., Tsarouhas K., Vitkina T.I., Mineeva E.E., Gvozdenko T.A., Antonyuk M.V. et al. Impact evaluation of environmental factors on respiratory function of asthma patients living in urban territory. Environ Pollut. 2018; 235: 489–96. https://doi.org/10.1016/j.envpol.2017.12.122</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng X., Ding H., Jiang L.N., Chen S.W., Zheng J.P., Qiu M. et al. Association between air pollutants and asthma emergency room visits and hospital admissions in time series studies: a systematic review and meta-analysis. PloS One. 2015; 10 (9): e0138146. https://doi.org/10.1371/journal.pone.0138146</mixed-citation><mixed-citation xml:lang="en">Zheng X., Ding H., Jiang L.N., Chen S.W., Zheng J.P., Qiu M. et al. Association between air pollutants and asthma emergency room visits and hospital admissions in time series studies: a systematic review and meta-analysis. PloS One. 2015; 10 (9): e0138146. https://doi.org/10.1371/journal.pone.0138146</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hansel N.N., Paulin L.M., Gassett A.J., Peng R.D., Neil A., Fan V.S. et al. Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ Open Resp Res. 2017; 4 (1): e000186. https://doi.org/10.1136/bmjresp-2017-000186</mixed-citation><mixed-citation xml:lang="en">Hansel N.N., Paulin L.M., Gassett A.J., Peng R.D., Neil A., Fan V.S. et al. Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ Open Resp Res. 2017; 4 (1): e000186. https://doi.org/10.1136/bmjresp-2017-000186</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Atkinson R.W., Kang S., Anderson H.R., Mills I.C., Walton H.A. Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: a systematic review and meta-analysis. Thorax. 2014; 69 (7): 660-5. https://doi.org/10.1136/thoraxjnl-2013-204492</mixed-citation><mixed-citation xml:lang="en">Atkinson R.W., Kang S., Anderson H.R., Mills I.C., Walton H.A. Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: a systematic review and meta-analysis. Thorax. 2014; 69 (7): 660–5. https://doi.org/10.1136/thoraxjnl-2013-204492</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wyzga R.E., Rohr A.C. Long-term particulate matter exposure: Attributing health effects to individual PM components. J Air Waste Manag Assoc. 2015; 65 (5): 523-43. https://doi.org/10.1136/thoraxjnl-2013-204492</mixed-citation><mixed-citation xml:lang="en">Wyzga R.E., Rohr A.C. Long-term particulate matter exposure: Attributing health effects to individual PM components. J Air Waste Manag Assoc. 2015; 65 (5): 523–43. https://doi.org/10.1136/thoraxjnl-2013-204492</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J., Huang J., Wang L., Chen C., Yang D., Jin M. et al. Urban particulate matter triggers lung inflammation via the ROS-MAPK-NF-κB signaling pathway. J Thorac Dis. 2017; 9 (11): 4398-412. https://doi.org/10.21037/jtd.2017.09.135</mixed-citation><mixed-citation xml:lang="en">Wang J., Huang J., Wang L., Chen C., Yang D., Jin M. et al. Urban particulate matter triggers lung inflammation via the ROS-MAPK-NF-κB signaling pathway. J Thorac Dis. 2017; 9 (11): 4398–412. https://doi.org/10.21037/jtd.2017.09.135</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Watterson T.L., Sorenson J., Martin R., Coulombe R.A.Jr. Effects of PM2.5 Collected from Cache Valley Utah in Human Bronchial Epithelial Cells. J Toxicol Environ Health A. 2007; 70 (20): 1731-44. https://doi.org/10.1080/15287390701457746</mixed-citation><mixed-citation xml:lang="en">Watterson T.L., Sorenson J., Martin R., Coulombe R.A.Jr. Effects of PM2.5 Collected from Cache Valley Utah in Human Bronchial Epithelial Cells. J Toxicol Environ Health A. 2007; 70 (20): 1731–44. https://doi.org/10.1080/15287390701457746</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Vitkina T.I., Yankova V.I., Gvozdenko T.A., Nazarenko A.V., Golokhvast K.S., Kuznetsov V.L. et al. The impact of multi-walled carbon nanotubes with different amount of metallic impurities on immunometabolic parameters in healthy volunteers. Food Chem Toxicol. 2016; 87: 138-47. https://doi.org/10.1016/j.fct.2015.11.023</mixed-citation><mixed-citation xml:lang="en">Vitkina T.I., Yankova V.I., Gvozdenko T.A., Nazarenko A.V., Golokhvast K.S., Kuznetsov V.L. et al. The impact of multi-walled carbon nanotubes with different amount of metallic impurities on immunometabolic parameters in healthy volunteers. Food Chem Toxicol. 2016; 87: 138–47. https://doi.org/10.1016/j.fct.2015.11.023</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Виткина Т.И., Денисенко Ю.К., Сидлецкая К.А. Изменение экспрессии рецептора к IL-6 на поверхности иммунокомпетентных клеток при прогрессировании хронической обструктивной болезни лёгких. Медицинская иммунология. 2017; 19 (2): 191-6. https://doi.org/10.15789/1563-0625-2017-2-191-196</mixed-citation><mixed-citation xml:lang="en">Vitkina T.I., Denisenko Yu.K., Sidletskaya K.A. Changes in the surface IL-6 receptor expression of distinct immune cells in progression of chronic obstructive pulmonary disease. Meditsinskaya immunologiya [Medical Immunology (Russia)]. 2017; 19 (2): 191–6. https://doi.org/10.15789/1563-0625-2017-2-191-196 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Виткина Т.И., Сидлецкая К.А. Роль интерлейкин-6 сигналинга в развитии системного воспаления при хронической обструктивной болезни лёгких. Бюллетень физиологии и патологии дыхания. 2018; 69: 96-106. https://doi.org/10.12737/article_5b9858ead1b5e3.93619630</mixed-citation><mixed-citation xml:lang="en">Vitkina T.I., Sidletskaya K.A. The role of interleukin-6 signaling in development of systemic inflammation in chronic obstructive pulmonary disease. Byulleten’ fiziologii i patologii dykhaniya. 2018; 69: 96–106. https://doi.org/10.12737/article_5b9858ead1b5e3.93619630 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Cosmi L., Liotta F., Annunziato F. Th17 regulating lower airway disease. Curr Opin Allergy Clin Immunol. 2016; 16 (1). https://doi.org/10.1097/ACI.0000000000000227</mixed-citation><mixed-citation xml:lang="en">Cosmi L., Liotta F., Annunziato F. Th17 regulating lower airway disease. Curr Opin Allergy Clin Immunol. 2016; 16 (1). https://doi.org/10.1097/ACI.0000000000000227</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H., Ying S., Wang S., Gu X., Weng Y., Peng W. et al. Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J. 2015; 9 (3): 330-41. https://doi.org/10.1111/crj.12147</mixed-citation><mixed-citation xml:lang="en">Wang H., Ying S., Wang S., Gu X., Weng Y., Peng W. et al. Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J. 2015; 9 (3): 330–41. https://doi.org/10.1111/crj.12147</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang X., Zhong W., Meng Q., Lin Q., Fang C., Huang X. et al. Ambient PM2. 5 exposure exacerbates severity of allergic asthma in previously sensitized mice. J Asthma. 2015; 52 (8): 785-94. https://doi.org/10.3109/02770903.2015.1036437</mixed-citation><mixed-citation xml:lang="en">Zhang X., Zhong W., Meng Q., Lin Q., Fang C., Huang X. et al. Ambient PM2. 5 exposure exacerbates severity of allergic asthma in previously sensitized mice. J Asthma. 2015; 52 (8): 785–94. https://doi.org/10.3109/02770903.2015.1036437</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">McCormick S.M., Heller N.M. Commentary: IL-4 and IL-13 receptors and signaling. Cytokine. 2015; 75 (1): 38-50. https://doi.org/10.1016/j.cyto.2015.05.023</mixed-citation><mixed-citation xml:lang="en">McCormick S.M., Heller N.M. Commentary: IL-4 and IL-13 receptors and signaling. Cytokine. 2015; 75 (1): 38–50. https://doi.org/10.1016/j.cyto.2015.05.023</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
